There is still so much we do not know about COVID-19. Likewise, there is little known about how this disease impacts mortality for cancer patients.
A study published in The Lancet evaluated and characterized the outcomes of patients with cancer and a diagnosis of COVID-19. The study analyzed data on 928 patients (21% of which were breast cancer patients) for 30 days. At the end of the 30 day evaluation, 13% of patients had died. They found that in addition to being diagnosed with cancer and COVID-19 other independent factors also impacted mortality rates. These included increased age, being male, smoking status, number of comorbidities and active cancer (rather than remission).
The study was able to conclude race/ethnicity, obesity status, cancer type, type of cancer therapy, and recent surgery were not associated with increased rates of mortality within the group.
Although much more research is needed to fully understand the impact of COVID-19 on mortality rates in cancer patients, it is important for those with active or a previous cancer diagnosis to take every precaution recommended by the CDC and local health organizations to reduce the risk of contracting the disease.
These include:
*Recommendations Provided by The US Center for Disease Control*
Author: Dr. Minas Chrysopoulo and Courtney Floyd
There is still so much we do not know about COVID-19. Likewise, there is little known about how this disease impacts mortality for cancer patients. This study provides insight.
No Comments